Cart
sales@molnova.com
PD173952
CAS No. 305820-75-1
PD173952( —— )
Catalog No. M34013 CAS No. 305820-75-1
PD173952 is a tyrosine (Src) kinase and Myt1 inhibitor with antitumor activity, inhibits Lyn, Abl and Csk, and induces Bcr-Abl-dependent hematopoietic cell apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 149 | Get Quote |
|
| 5MG | 244 | Get Quote |
|
| 10MG | 363 | Get Quote |
|
| 25MG | 578 | Get Quote |
|
| 50MG | 817 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePD173952
-
NoteResearch use only, not for human use.
-
Brief DescriptionPD173952 is a tyrosine (Src) kinase and Myt1 inhibitor with antitumor activity, inhibits Lyn, Abl and Csk, and induces Bcr-Abl-dependent hematopoietic cell apoptosis.
-
DescriptionPD173952 is a tyrosine kinases inhibitor with IC50s of 0.3, 1.7 and 6.6 nM against Lyn, Abl and Csk, respectively. PD173952 is also a potent Myt1 kinase inhibitor with a Ki of 8.1 nM. PD173952 induces apoptosis.
-
In VitroWestern Blot Analysis Cell Line:K562 cells Concentration:0, 25, 50, 100, 200, 500 and 1000 nM Incubation Time:12 h Result:Inhibited tyrosine phosphorylation of p210Bcr-Abl and CrkL.Cell Viability Assay Cell Line:K562 cells Concentration:0.5 μM Incubation Time:1-4 days Result:Caused cell death in a time-dependent manner.Western Blot Analysis Cell Line:K562 and MEG-01 cells Concentration:0.5 μM Incubation Time:24 and 48 h Result:85-kDa PARP fragment was detected.
-
In Vivo——
-
Synonyms——
-
PathwayAngiogenesis
-
TargetSrc
-
RecptorSrc | Wee1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number305820-75-1
-
Formula Weight482.36
-
Molecular FormulaC24H21Cl2N5O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C1C(=CC=2C=NC(=NC2N1C)NC3=CC=C(C=C3)N4CCOCC4)C5=C(Cl)C=CC=C5Cl
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dorsey JF, et al. Interleukin-3 protects Bcr-Abl-transformed hematopoietic progenitor cells from apoptosis induced by Bcr-Abl tyrosine kinase inhibitors. Leukemia. 2002 Sep;16(9):1589-95.?
molnova catalog
related products
-
WAY-303290
WAY-303290 inhibits the pY binding site of tyrosine kinase p56lck SH2 domain.
-
AZ12672857
AZ12672857 is an inhibitor of EphB4 with IC50 of 1.3 nM. AZ12672857 inhibits cell proliferation of Src transfected 3T3 cells with IC50 of 2 nM and autophosphorylation of EphB4 in transfected CHO-K1 cells with IC50 of 9 nM.
-
AP23846
AP23846 is a novel and potent Src family kinase inhibitor that reduces vascular endothelial growth factor and interleukin-8 expression and abrogates downstream angiogenic processes in human solid tumor cell lines.
